A Single-centre Study Evaluating the Performance and Acceptance of the Hilo Band Cuffless Blood Pressure Medical Device in the Normo-, Hypo- and Hyper-tensive Young Population: a Comparison With the 24-h Ambulatory Blood Pressure Monitoring (ABPM)
NCT ID: NCT07072689
Last Updated: 2025-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
40 participants
OBSERVATIONAL
2025-12-01
2028-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The 24-hour Ambulatory Blood Pressure Monitoring (24-hour ABPM) device allows for continuous blood pressure monitoring over a 24-hour period and is currently considered the gold standard for diagnosing hypertension. However, it is expensive, time-consuming for healthcare personnel, bulky, and often uncomfortable to wear-especially during the night.
Recently, other blood pressure monitoring devices have entered the market. One of them is the Aktiia bracelet, renamed as Hilo band as of 8 april 2025, (Hilo band SA, Neuchâtel, Switzerland), CE-marked, which estimates blood pressure and heart rate using a pulse wave analysis (PWA) technique. Hilo band is non-invasive, comfortable to wear, and allows for long-term blood pressure monitoring.
However, there is insufficient data to support the use of Hilo band in healthcare settings for the diagnosis and monitoring of hypertension. In one study, Hilo band was compared to the 24-hour ABPM only for daytime blood pressure readings in a population enrolled in a cardiac rehabilitation program, and thus was not tested in apparently 'healthy' individuals who may be hypertensive. Another study assessed Hilo band's performance compared to double auscultation in older adults aged 65 to 85 years in different body positions (sitting, standing, and lying down), and therefore did not include a younger population.
In our research project, we aim to evaluate the performance of Hilo band compared to 24-hour ABPM in a younger population, considering both daytime and nighttime blood pressure measurements.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)
NCT07240831
Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance
NCT00139984
Comparing PPG-based Blood Pressure Measurement to the Gold Standard Manometer
NCT03810586
Home Versus Ambulatory Monitoring, Diurnal Blood Pressure Profile, Detection of Non-Dippers
NCT01460732
A Study of Continuous Blood Pressure Monitoring in Healthy Participants
NCT05692869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Population 2
No indications for blood pressure measurements
No interventions assigned to this group
Population 1
Indications to receive blood pressure measurement of 24-hours
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed Consent signed by the subject
* 21-35 years of age
* Functional internet phone connection
* Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant
Population 1:
* Informed Consent signed by the subject
* 21-35 years of age
* Clinical indication for receiving a 24-hour blood pressure measurement
* Functional internet phone connection
* Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant
Exclusion Criteria
* Atrial fibrillation
* Subjects with arrhythmia
* Patients suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \< 30mL / min / 1.73 m2), untreated hyper-/ hypothyroidism, pheochromocytoma, or arteriovenous fistula
* Interarm Systolic Blood Pressure (SBP) difference over 10% or Diastolic Blood Pressure (DBP) difference over 10%
* Arm paralysis
* Amputated upper limb
* Arm trembling or shivering
* Upper arm circumference \> 64 cm
* Wrist circumference \> 22 cm
* Exfoliative skin diseases and lymphoedema or damaged/injured skin at the wrist
* Pregnant women
* Individuals with lack of judgment/mental illness
* Sleepwalking and severe insomnia
* Pica disorder
21 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Simonetti Giacomo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simonetti Giacomo
Prof. Dr. med
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giacomo Simonetti, Prof. Dr. med
Role: PRINCIPAL_INVESTIGATOR
Ente Ospedaliero cantonale (EOC)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ente Ospedaliero Cantonale
Bellinzona, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IPSI-HYPE-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.